| Report ID |
11234 |
| Drug Identification Number |
02212188 |
| Brand name |
IMITREX INJECTION 12MG/ML |
| Common or Proper name |
Sumatriptan succinate injection |
| Company Name |
GLAXOSMITHKLINE INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
SUMATRIPTAN |
| Strength(s) |
12MG |
| Dosage form(s) |
LIQUID |
| Route of administration |
SUBCUTANEOUS |
| Packaging size |
5x0.5mL |
| ATC code |
N02CC |
| ATC description |
ANTIMIGRAINE PREPARATIONS |
| Reason for shortage |
Shortage of an active ingredient. |
| Anticipated start date |
|
| Actual start date |
2017-06-26 |
| Estimated end date |
2018-06-29 |
| Actual end date |
2018-06-26 |
| Shortage status |
Resolved |
| Updated date |
2018-06-27 |
| Company comments |
Supply released July 2017 and August 2017 with limited quantity |
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
1-800-387-7374 |
